Pharmaceutical R&D

OpenAI to Acquire Orchestra Bio for AI-Powered Drug R&D

OpenAI is acquiring Orchestra Bio to bring AI-powered operations into life sciences R&D, aiming to accelerate drug development and advance treatments faster.